Although previous studies indicated that cDC1 are important for cross-priming CD8+ T cells,71 we demonstrated that they are not essential to elicit effector T cell response to optimized AAV6 vaccine-encoded tumor antigens. The gene discussed is CD8A; the disease is neoplasm.